DK228081A - Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner - Google Patents
Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vaccinerInfo
- Publication number
- DK228081A DK228081A DK228081A DK228081A DK228081A DK 228081 A DK228081 A DK 228081A DK 228081 A DK228081 A DK 228081A DK 228081 A DK228081 A DK 228081A DK 228081 A DK228081 A DK 228081A
- Authority
- DK
- Denmark
- Prior art keywords
- vaccin
- procedure
- preparation
- viral glycoprotein
- glycoprotein antigens
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8012522A FR2483779A1 (fr) | 1980-06-05 | 1980-06-05 | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK228081A true DK228081A (da) | 1981-12-06 |
Family
ID=9242745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK228081A DK228081A (da) | 1980-06-05 | 1981-05-25 | Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner |
Country Status (19)
Country | Link |
---|---|
US (1) | US4344935A (de) |
EP (1) | EP0041880B1 (de) |
JP (1) | JPS5726624A (de) |
AR (1) | AR228865A1 (de) |
AT (1) | ATE3239T1 (de) |
AU (1) | AU546088B2 (de) |
CA (1) | CA1174598A (de) |
DE (1) | DE3160264D1 (de) |
DK (1) | DK228081A (de) |
ES (1) | ES8203225A1 (de) |
FI (1) | FI811685L (de) |
FR (1) | FR2483779A1 (de) |
GR (1) | GR74610B (de) |
IE (1) | IE51226B1 (de) |
IL (1) | IL62913A (de) |
NO (1) | NO811873L (de) |
NZ (1) | NZ197306A (de) |
PT (1) | PT73032B (de) |
ZA (1) | ZA813479B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721675A (en) * | 1982-02-01 | 1988-01-26 | Abbott Laboratories | Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system |
US4645666A (en) * | 1982-06-08 | 1987-02-24 | The Regents Of The University Of California | Vaccine for bluetongue disease employing platinum compounds |
GB8502096D0 (en) * | 1985-01-28 | 1985-02-27 | Medical Res Council | Influenza vaccine |
NZ224422A (en) | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
US4975119A (en) * | 1989-04-25 | 1990-12-04 | Rheox, Inc. | Liquid antisettling agents for organic coating compositions |
US5741493A (en) * | 1991-01-24 | 1998-04-21 | Pasteur Merieux Serums Et Vaccins | Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive |
FR2671974A1 (fr) * | 1991-01-24 | 1992-07-31 | Pasteur Merieux Serums Vacc | Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal. |
US6780630B1 (en) * | 1992-07-10 | 2004-08-24 | Baylor College Of Medicine | Parenteral immunization against rotavirus |
FR2723740B1 (fr) * | 1994-08-16 | 1996-11-08 | Pasteur Merieux Serums Vacc | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications |
DE69629812T2 (de) | 1995-06-14 | 2004-04-01 | Baylor College Of Medicine, Houston | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 |
US6673355B1 (en) | 1995-06-14 | 2004-01-06 | Baylor College Of Medicine | Rotavirus enterotoxin NSP4 and methods of using same |
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE661402A (de) | 1964-03-20 | |||
US3847737A (en) * | 1965-03-22 | 1974-11-12 | A Kanarek | Inactivation of myxoviruses and method of preparing a vaccine therefrom |
US3629470A (en) * | 1968-04-08 | 1971-12-21 | Burroughs Wellcome Co | Process for purification of animal rna viruses |
BR6915288D0 (pt) * | 1969-03-15 | 1973-02-08 | Bayer Ag | Processo para a purificacao de solucoes do virus da febre aftosa |
US3989818A (en) * | 1970-08-14 | 1976-11-02 | South African Inventions Development Corporation | Influenza virus vaccine |
US3790552A (en) * | 1972-03-16 | 1974-02-05 | Us Health | Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol |
US3962421A (en) * | 1973-06-18 | 1976-06-08 | American Home Products Corporation | Method for the disruption of lipid-containing viruses |
GB1486557A (en) | 1973-10-18 | 1977-09-21 | Flockhart & Co | Process for the preparation of pyrogen-free sub-unit vaccine |
US3951937A (en) * | 1973-12-20 | 1976-04-20 | The Community Blood Council Of Greater New York, Inc. | Large scale purification of hepatitis type B antigen using polyethylene glycol |
US4140762A (en) * | 1974-01-14 | 1979-02-20 | Sandoz Ltd. | Influenza sub-unit vaccine |
US4064232A (en) * | 1974-01-14 | 1977-12-20 | Sandoz Ltd. | Process for isolating the immunogenic components of influenza viruses |
AU507149B2 (en) | 1975-01-16 | 1980-02-07 | Mount Sinai School Of Medicine Of The City University Of New York, The | Method of influenza immunization |
FR2422720A2 (fr) | 1977-04-26 | 1979-11-09 | Elf Aquitaine | Separation et purification de proteines par chromatographie |
FI66020C (fi) * | 1977-09-19 | 1984-08-10 | Merck & Co Inc | Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2 |
DE2750045A1 (de) * | 1977-11-09 | 1979-05-10 | Behringwerke Ag | Verfahren zur entfernung von detergentien aus virusantigensuspensionen |
-
1980
- 1980-06-05 FR FR8012522A patent/FR2483779A1/fr active Granted
-
1981
- 1981-05-11 AR AR285278A patent/AR228865A1/es active
- 1981-05-14 PT PT73032A patent/PT73032B/pt unknown
- 1981-05-19 US US06/265,084 patent/US4344935A/en not_active Expired - Fee Related
- 1981-05-20 IL IL62913A patent/IL62913A/xx unknown
- 1981-05-22 AT AT81400815T patent/ATE3239T1/de not_active IP Right Cessation
- 1981-05-22 EP EP81400815A patent/EP0041880B1/de not_active Expired
- 1981-05-22 DE DE8181400815T patent/DE3160264D1/de not_active Expired
- 1981-05-25 ZA ZA00813479A patent/ZA813479B/xx unknown
- 1981-05-25 DK DK228081A patent/DK228081A/da not_active Application Discontinuation
- 1981-05-26 IE IE1168/81A patent/IE51226B1/en unknown
- 1981-05-27 ES ES502549A patent/ES8203225A1/es not_active Expired
- 1981-05-29 AU AU71170/81A patent/AU546088B2/en not_active Ceased
- 1981-06-01 FI FI811685A patent/FI811685L/fi not_active Application Discontinuation
- 1981-06-02 CA CA000378801A patent/CA1174598A/en not_active Expired
- 1981-06-02 GR GR65127A patent/GR74610B/el unknown
- 1981-06-03 NO NO811873A patent/NO811873L/no unknown
- 1981-06-04 JP JP8504581A patent/JPS5726624A/ja active Pending
- 1981-06-04 NZ NZ197306A patent/NZ197306A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3160264D1 (en) | 1983-06-16 |
JPS5726624A (en) | 1982-02-12 |
PT73032B (fr) | 1982-07-01 |
AR228865A1 (es) | 1983-04-29 |
AU546088B2 (en) | 1985-08-15 |
IE51226B1 (en) | 1986-11-12 |
EP0041880A1 (de) | 1981-12-16 |
ES502549A0 (es) | 1982-04-01 |
FR2483779A1 (fr) | 1981-12-11 |
ZA813479B (en) | 1982-06-30 |
US4344935A (en) | 1982-08-17 |
FI811685L (fi) | 1981-12-06 |
IL62913A0 (en) | 1981-07-31 |
GR74610B (de) | 1984-06-29 |
CA1174598A (en) | 1984-09-18 |
NO811873L (no) | 1981-12-07 |
FR2483779B1 (de) | 1983-07-22 |
PT73032A (fr) | 1981-06-01 |
NZ197306A (en) | 1984-03-16 |
ES8203225A1 (es) | 1982-04-01 |
EP0041880B1 (de) | 1983-05-11 |
ATE3239T1 (de) | 1983-05-15 |
IE811168L (en) | 1981-12-05 |
AU7117081A (en) | 1981-12-10 |
IL62913A (en) | 1984-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK497682A (da) | Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge | |
DK228081A (da) | Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner | |
DK169986A (da) | Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen | |
DK44381A (da) | Fremgangsmaade og saet til fremstilling af taage | |
DK154763C (da) | Fremgangsmaade til fremstilling af norfloxacin | |
DK333183A (da) | Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner | |
DK427281A (da) | Fremgangsmaade til fremstilling af terapeutiske praeparater | |
DK340383D0 (da) | Monoklone igm-antistoffer og fremgangsmade til deres fremstilling | |
DK364481A (da) | Fremgangsmaade til fremstilling af caprylolactamer | |
DK282384A (da) | Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet | |
DK165336C (da) | Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling | |
DK296281A (da) | Fremgangsmaade til fremstilling af aminocyklopentanonamider | |
DK166581A (da) | Fremgangsmaade til fremstilling af peptider | |
DK155886D0 (da) | Vaccine og fremgangsmaade til fremstilling af denne | |
DK579181A (da) | Fremgangsmaade til fremstilling af diarylthiophener | |
DK33181A (da) | Fremgangsmaade til fremstilling af et interferonlignende protein | |
DK482583D0 (da) | Dna-sekvens, dna-strukturer og fremgangsmade til fremstilling af penicillin-acylase under anvendelse deraf | |
DK188181A (da) | Fremgangsmaade til fremstilling af halogenerede steroider | |
DK467181A (da) | Virusmutant af shv, vaccine indeholdende denne mutant og fremgangsmaade til fremstilling af vaccinen | |
DK47681A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater | |
DK153841C (da) | Fremgangsmaade til fremstilling af ranitidin | |
DK12581A (da) | Fremgangsmaade til fremstilling af kijanimicin | |
DK273183D0 (da) | Fremgangsmade til fremstilling af amidiner | |
DK342981A (da) | Fremgangsmaade til selektiv fremstilling af m-chloraniliner | |
DK440281A (da) | Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |